ROYAL BANK OF CANADA - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 4 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$371,000
+19.7%
17,974
+70.9%
0.00%
Q2 2023$310,000
+48.3%
10,516
+15.7%
0.00%
Q1 2023$209,000
-60.9%
9,087
-52.7%
0.00%
Q4 2022$535,000
+335.0%
19,221
+378.7%
0.00%
Q3 2022$123,000
-68.8%
4,015
-70.1%
0.00%
Q2 2022$394,000
+46.5%
13,407
+60.0%
0.00%
Q1 2022$269,000
-34.7%
8,381
-9.3%
0.00%
Q4 2021$412,000
+101.0%
9,243
+127.2%
0.00%
Q3 2021$205,000
-77.0%
4,068
-64.2%
0.00%
Q2 2021$892,000
-56.6%
11,364
-68.4%
0.00%
-100.0%
Q1 2021$2,055,000
+2.5%
35,981
+50.3%
0.00%0.0%
Q4 2020$2,005,000
+3417.5%
23,941
+1396.3%
0.00%
Q3 2020$57,000
+83.9%
1,600
+24.0%
0.00%
Q2 2020$31,000
+24.0%
1,290
-10.6%
0.00%
Q1 2020$25,000
-73.1%
1,443
-73.0%
0.00%
Q4 2019$93,000
+1450.0%
5,348
+1237.0%
0.00%
Q3 2019$6,000
-25.0%
4000.0%0.00%
Q2 2019$8,000
-11.1%
400
-1.7%
0.00%
Q1 2019$9,000
-43.8%
407
-48.2%
0.00%
Q4 2018$16,000
-52.9%
786
-48.6%
0.00%
Q3 2018$34,000
+3300.0%
1,528
+3453.5%
0.00%
Q2 2018$1,0000.0%43
-36.8%
0.00%
Q1 2018$1,000
-93.8%
68
-93.2%
0.00%
Q4 2017$16,0001,0000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$219,569,00028.65%
ARCH Venture Management, LLC 5,168,749$152,116,00018.54%
Casdin Capital, LLC 1,500,000$44,145,0003.73%
Flagship Pioneering Inc. 2,619,968$77,106,0002.90%
Yiheng Capital Management, L.P. 1,014,684$29,862,0001.71%
SECTORAL ASSET MANAGEMENT INC 202,100$5,948,0001.20%
GILDER GAGNON HOWE & CO LLC 1,956,820$57,589,0001.03%
Artal Group S.A. 600,000$17,658,0000.94%
Temasek Holdings (Private) Ltd 5,369,487$158,024,0020.87%
BRANDYWINE MANAGERS, LLC 9,601$283,0000.69%
View complete list of DENALI THERAPEUTICS INC shareholders